Black Diamond Therapeutics Inc Dividends
The next dividend date for Black Diamond Therapeutics Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Black Diamond Therapeutics Inc (BDTX)
More About Black Diamond Therapeutics Inc
Black Diamond Therapeutics, Inc., a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is BDTX-1535, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in Phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as Phase 1 clinical trial to treat glioblastoma. It is also developing BDTX-4933, a brain-penetrant RAF MasterKey inhibitor targeting KRAS, NRAS, and BRAF alterations in solid tumors that is in Phase 1 clinical trial. In addition, the company is developing BDTX-4876, a MasterKey inhibitor of oncogenic FGFR2/3 mutations with selectivity versus FGFR1/4, which is in preclinical stage. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Owning Black Diamond Therapeutics Inc Stock on the Dividend Date
If you own Black Diamond Therapeutics Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Black Diamond Therapeutics Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Black Diamond Therapeutics Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Black Diamond Therapeutics Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Black Diamond Therapeutics Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Black Diamond Therapeutics Inc Dividends
You can contact us any time if you would like to ask questions about Black Diamond Therapeutics Inc dividends or anything else related to the stock market.